RO90-7501 is an amyloid-β42 (Aβ42) fibril assembly inhibitor that reduces Aβ42-induced cytotoxicity (EC50 = 2 μM); it inhibits ATM phosphorylation and DNA repair; selectively enhances TLR3- and RLR ligand-induced IFN-β gene expression and antiviral responses; inhibits protein phosphatase 5 (PP5) in a TPR-dependent manner; exhibits significant radiosensitizing effects in cervical cancer cells; enhances radiosensitivity, increases apoptosis, and impairs cell cycle progression after irradiation; suppresses radiation-induced phosphorylation of ATM and its downstream targets (e.g., H2AX, Chk1, Chk2); potentiates poly(I:C)-induced IFN-β promoter activation and antiviral activity; and significantly delays tumor growth and reduces tumor volume in vivo when combined with irradiation.